New User? Sign Up | Sign In

Insider Trading - Azelby Robert

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for Azelby Robert

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2018-02-12
Sale(A)
2018-02-15
7:31 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
4,159 $85.55 $355,802 89,612
(Direct)
View
2018-02-12
Sale
2018-02-14
7:24 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
4,157 $85.55 $355,631 89,614
(Direct)
View
2018-02-07
Sale
2018-02-09
7:27 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
3,497 $85.77 $299,938 93,771
(Direct)
View
2018-01-31
Sale
2018-02-02
7:26 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
4,167 $85.78 $357,445 96,471
(Direct)
View
2018-01-22
Sale
2018-01-24
6:46 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
102,539 $86.25 $8,843,989 70,832
(Direct)
View
2018-01-17
Sale
2018-01-19
9:00 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
29,131 $68.61 $1,998,603 70,832
(Direct)
View
2017-12-18
Sale
2017-12-20
4:37 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
1,816 $44.96 $81,647 70,832
(Direct)
View
2017-11-02
Sale
2017-11-03
7:30 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
6,666 $54.95 $366,297 73,332
(Direct)
View
2017-09-13
Sale
2017-09-14
7:31 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
12,850 $44.95 $577,608 37,439
(Direct)
View
2017-08-29
Sale
2017-08-31
7:44 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
12,869 $39.95 $514,117 50,289
(Direct)
View
2016-11-08
Sale
2016-11-10
8:56 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
12,921 $24.14 $311,848 35,719
(Direct)
View
(A) Indicate amendment filing.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-02-26
Option Award
2020-02-27
4:48 pm
2021-02-26
2027-02-26
IMMUNOMEDICS INC IMMU Azelby Robert
Director
22,500 $16.36 22,500
(Direct)
View
2019-10-22
Disposition
2019-10-24
6:52 pm
N/A
2028-06-12
ALDER BIOPHARMACEUTICALS INC ALDR Azelby Robert
CEO
1,000,000 $16.2 0
(Direct)
View
2019-10-22
Disposition
2019-10-24
6:52 pm
N/A
2029-02-05
ALDER BIOPHARMACEUTICALS INC ALDR Azelby Robert
CEO
505,000 $14 0
(Direct)
View
2019-10-22
Disposition
2019-10-24
6:52 pm
N/A
N/A
ALDER BIOPHARMACEUTICALS INC ALDR Azelby Robert
CEO
15,000 $0 0
(Direct)
View
2019-10-22
Disposition
2019-10-24
6:52 pm
2019-04-23
2028-06-12
ALDER BIOPHARMACEUTICALS INC ALDR Azelby Robert
CEO
150,000 $16.2 0
(Direct)
View
2019-06-06
Option Award
2019-06-07
4:46 pm
N/A
2029-06-06
Clovis Oncology Inc. CLVS Azelby Robert
Director
28,882 $14.66 28,882
(Direct)
View
2019-04-23
Option Award
2019-04-25
6:56 pm
2019-04-23
2028-06-12
ALDER BIOPHARMACEUTICALS INC ALDR Azelby Robert
CEO
150,000 $16.2 150,000
(Direct)
View
2019-02-06
Option Award
2019-02-08
4:40 pm
N/A
2029-02-05
ALDER BIOPHARMACEUTICALS INC ALDR Azelby Robert
CEO
505,000 $14 15,000
(Direct)
View
2019-02-06
Option Award
2019-02-08
4:40 pm
N/A
N/A
ALDER BIOPHARMACEUTICALS INC ALDR Azelby Robert
CEO
15,000 $0 15,000
(Direct)
View
2018-10-11
Option Award
2018-10-15
6:44 pm
N/A
2028-10-11
Clovis Oncology Inc. CLVS Azelby Robert
Director
25,848 $27.92 25,848
(Direct)
View
2018-06-13
Option Award
2018-06-15
4:02 pm
N/A
2028-06-12
ALDER BIOPHARMACEUTICALS INC ALDR Azelby Robert
CEO
1,000,000 $16.2 1,000,000
(Direct)
View
2018-03-09
Disposition
2018-03-13
6:07 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Azelby Robert
Director
12,437 $0 0
(Direct)
View
2018-03-09
Disposition
2018-03-13
6:07 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Azelby Robert
Director
13,927 $0 0
(Direct)
View
2018-03-05
Disposition
2018-03-07
6:13 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
7,500 $0 0
(Direct)
View
2018-03-05
Disposition
2018-03-07
6:13 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
20,580 $0 0
(Direct)
View
2018-03-05
Disposition
2018-03-07
6:13 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
25,639 $0 0
(Direct)
View
2018-03-05
Disposition
2018-03-07
6:13 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
35,893 $0 0
(Direct)
View
2018-03-05
Disposition
2018-03-07
6:13 pm
N/A
2025-10-31
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
93,294 $51.76 0
(Direct)
View
2018-03-05
Disposition
2018-03-07
6:13 pm
N/A
2026-11-07
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
30,002 $25.29 0
(Direct)
View
2018-03-05
Disposition
2018-03-07
6:13 pm
N/A
2027-02-06
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
98,545 $20.76 0
(Direct)
View
2018-02-07
Tax Withholding
2018-02-09
7:27 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
2,700 $85.49 93,771
(Direct)
View
2018-02-07
Exercise
2018-02-09
7:27 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
834 $25.29 93,771
(Direct)
View
2018-02-07
Exercise
2018-02-09
7:27 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
2,663 $20.76 93,771
(Direct)
View
2018-02-07
Exercise
2018-02-09
7:27 pm
N/A
2026-11-07
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
834 $25.29 93,771
(Direct)
View
2018-02-07
Exercise
2018-02-09
7:27 pm
N/A
2027-02-06
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
2,663 $20.76 93,771
(Direct)
View
2018-01-31
Option Award
2018-02-02
7:26 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
25,639 $0 96,471
(Direct)
View
2018-01-31
Exercise
2018-02-02
7:26 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
4,167 $51.76 96,471
(Direct)
View
2018-01-31
Exercise
2018-02-02
7:26 pm
N/A
2025-10-31
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
4,167 $51.76 96,471
(Direct)
View
2018-01-22
Exercise
2018-01-24
6:46 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
102,539 $51.76 70,832
(Direct)
View
2018-01-22
Exercise
2018-01-24
6:46 pm
N/A
2025-10-31
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
102,539 $51.76 70,832
(Direct)
View
2018-01-17
Exercise
2018-01-19
9:00 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
2,498 $25.29 70,832
(Direct)
View
2018-01-17
Exercise
2018-01-19
9:00 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
26,633 $20.76 70,832
(Direct)
View
2018-01-17
Exercise
2018-01-19
9:00 pm
N/A
2026-11-07
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
2,498 $25.29 70,832
(Direct)
View
2018-01-17
Exercise
2018-01-19
9:00 pm
N/A
2027-02-06
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
26,633 $20.76 70,832
(Direct)
View
2017-11-08
Tax Withholding
2017-11-09
7:32 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
684 $55.98 72,648
(Direct)
View
2017-11-02
Exercise
2017-11-03
7:30 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
6,666 $25.29 73,332
(Direct)
View
2017-11-02
Exercise
2017-11-03
7:30 pm
N/A
2026-11-07
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
6,666 $25.29 73,332
(Direct)
View
2017-10-20
Option Award
2017-10-20
8:24 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
35,893 $0 73,332
(Direct)
View
2017-06-09
Option Award
2017-06-13
4:37 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Azelby Robert
Director
13,927 $0 13,927
(Direct)
View
2017-04-03
Option Award
2017-04-04
5:43 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Azelby Robert
Director
12,437 $0 12,437
(Direct)
View
2017-02-07
Option Award
2017-02-09
7:31 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
27,439 $0 127,841
(Direct)
View
2017-02-07
Option Award
2017-02-09
7:31 pm
N/A
2027-02-06
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
127,841 $20.76 127,841
(Direct)
View
2016-11-08
Option Award
2016-11-10
8:56 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
10,000 $0 35,719
(Direct)
View
2016-11-08
Option Award
2016-11-10
8:56 pm
N/A
2026-11-07
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
40,000 $25.29 35,719
(Direct)
View
2015-11-01
Option Award
2015-11-02
5:02 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
See Remarks
38,640 $0 200,000
(Direct)
View
2015-11-01
Option Award
2015-11-02
5:02 pm
N/A
2025-10-31
Juno Therapeutics Inc. JUNO Azelby Robert
See Remarks
200,000 $51.76 200,000
(Direct)
View